NEWS & EVENTS

2020.08 Taiwan FDA granted the Active Pharmaceutical Ingredient Market License of Pemetrexed Disodium Hemipentahydrate

Taiwan FDA granted the in-house developed Generic Oncology (Cytotoxic) Active Pharmaceutical Ingredient Market License of Pemetrexed Disodium Hemipentahydrate, Registration Number: MOHW-PM060543